News

The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside ...
FDA Wants AI to ‘Radically Increase Efficiency’ According to an article published in JAMA, the FDA is exploring the possibility of using generative AI technology to “radically increase ...
Joe Lonsdale, co-founder of the large government contractor Palantir, wants to embed a team of 15 to 20 “elite engineers” ...
As far as the AI goes, the FDA had already been testing an "AI-assisted scientific review pilot" back on May 8, the JAMA article notes. Last week, that was revealed to be "Elsa," an LLM running on ...
Some aspects of the proposals outlined in JAMA were met with ... The FDA officials wrote that AI held the promise to “radically increase efficiency” in examining as many as 500,000 pages ...
The FDA has launched a pilot program using generative AI to help expedite the review of drug ... according to a viewpoint article published June 10 in JAMA Network. The FDA debuted its AI system, ...
Food and Drug Administration’s June 2025 JAMA article highlights AI-assisted reviews, food dye phase-out, and cost-cutting reforms under Commissioner Makary’s leader ...
In this episode presented by IQVIA, BioSpace's head of insights Lori Ellis discusses the FDA's first draft guidance for AI in ...
The U.S. Food and Drug Administration (FDA) says it plans to use artificial ... That's one of several priorities federal officials detailed June 10 in JAMA. They said AI could help shorten ...
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of new drugs and medical devices.